Pharmaceutical & Medical Devices
Today’s pharmaceutical and medical device organizations operate amidst a highly competitive marketplace and increasing regulatory and government scrutiny. Drawing on unmatched experience, specialized knowledge and a collaborative, action-oriented approach, Huron has delivered customized financial and operational solutions that have provided significant value for more than 60 leading life sciences companies. 
Pharmaceutical & Medical Devices INSIGHTS
Resource: Clinical Research Management Briefing May 23, 2016
The Clinical Research Management Briefing (CRMB) is a weekly newsletter that Huron Consulting Group sends out to clients and interested parties.» MORE

Update: CMS Issues Guidance on Drug Category Narrow Exception
CMS issued manufacturer release number 98, which provides guidance on categorizing drugs required to be marketed under an original new drug application (NDA) but may otherwise meet the non-innovator multiple source drug definition.» MORE

Update: Texas Eliminates Drug Price Reporting Requirements
Texas Health and Human Service Commission (TX HHSC) has adopted and published a final rule eliminating the Texas Medicaid monthly drug price reporting requirement, effective May 15, 2016.» MORE


Related Expertise
PROFESSIONALS
Alt text

David Gilman

Managing Director

Lester Cheng

Lester Cheng

Managing Director

Alt text

Marc Tomassi

Managing Director

Mark Linver

Mark Linver

Managing Director

Paul J. Silver

Paul J. Silver

Managing Director and Practice Leader

Resource

International Medical Device Compliance Code Compendium

First published as a bound reference guide in 2007, the International Medical Device Compliance Code Compendium provides a comprehensive listing of region- and country-level codes of conduct developed by self-regulatory bodies in the medical device sector as well as comparative analyses with the most recent guidance provided by AdvaMed.